🇺🇸 FDA
Patent

US 11542506

Compositions and methods of treating amyotrophic lateral sclerosis (ALS)

granted A61PA61P21/02A61P25/28

Quick answer

US patent 11542506 (Compositions and methods of treating amyotrophic lateral sclerosis (ALS)) held by VOYAGER THERAPEUTICS, INC. expires Mon Dec 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
VOYAGER THERAPEUTICS, INC.
Grant date
Tue Jan 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61P, A61P21/02, A61P25/28, A61P43/00